Virtual Medicinal Product (VMP)
-
Raltitrexed 2mg powder for solution for infusion vials
Name Details
Current Name
Raltitrexed 2mg powder for solution for infusion vials
|
Start Date
14-01-2009
|
End Date
|
Previous Name
Raltitrexed 2mg powder for solution for injection vials
|
Start Date
11-06-2004
|
End Date
13-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder for solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01BA03
BNF |
Current BNF
08010300
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08010300
|
Start Date
20-07-2006
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41794111000001107 |
12-05-2023 |
|
326916001 |
29-03-2004 |
11-05-2023 |
VMP Ingredients
VMP ingredients table
Raltitrexed |
Based on Ingredient Substance |
|
2 mg |
|
Name
Raltitrexed
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
2.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Raltitrexed
-
VMP
(Current) Raltitrexed 2mg powder for solution ...
Virtual Medicinal Product Pack (VMPP) Information